ArticleOncogene2022

Fatty acid oxidation enzyme Δ3, Δ2-enoyl-CoA isomerase 1 (ECI1) drives aggressive tumor phenotype and predicts poor clinical outcome in prostate cancer patients.

Yogesh M Bramhecha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.